600 people with Parkinson’s who:
• Live in the UK or the US
• Were diagnosed in 2020 or earlier
• Experience movement symptoms
• And currently take levodopa (eg Sinemet or Madopar) or another dopamine replacement drug
Unfortunately, people who have already had an advanced therapy to treat their Parkinson’s, such as DBS, focused ultrasound or an infusion pump, are unable to take part.